The result of network pharmacology showed that the PI3K/Akt signaling pathway may be associated with the anti-obesity effect of ABS by improving lipid metabolism, which will require further validation of its specific regulation by the ABS. This evidence concerns the gene AKT1 and obesity due to melanocortin 4 receptor deficiency.